Related Experiment Video
Updated: Apr 21, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S Sabharwal1, Paul T Schumacker1
1Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Abstract:
Mitochondria cooperate with their host cells by contributing to bioenergetics, metabolism, biosynthesis, and cell death or survival functions. Reactive oxygen species (ROS) generated by mitochondria participate in stress signalling in normal cells but also contribute to the initiation of nuclear or mitochondrial DNA mutations that promote neoplastic transformation. In cancer cells, mitochondrial ROS amplify the tumorigenic phenotype and accelerate the accumulation of additional mutations that lead to metastatic behaviour. As mitochondria carry out important functions in normal cells, disabling their function is not a feasible therapy for cancer. However, ROS signalling contributes to proliferation and survival in many cancers, so the targeted disruption of mitochondria-to-cell redox communication represents a promising avenue for future therapy.
Insights
Mitochondria generate reactive oxygen species (ROS) that drive cancer growth and mutations. Targeting mitochondria-to-cell redox communication, rather than disabling mitochondria, offers a promising cancer therapy strategy.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Mitochondria are crucial for cellular functions including energy production and metabolism.
- Mitochondria-derived reactive oxygen species (ROS) play dual roles in normal cells and cancer.
- Mitochondrial ROS contribute to DNA mutations and cancer development, including metastasis.
Purpose of the Study:
- To explore the role of mitochondrial ROS in cancer progression.
- To evaluate the potential of targeting mitochondria-redox signaling for cancer therapy.
Main Methods:
- Review of existing literature on mitochondrial function and ROS signaling in cancer.
- Analysis of the contribution of mitochondrial ROS to neoplastic transformation and metastasis.
Main Results:
- Mitochondrial ROS promote cancer cell proliferation, survival, and mutation accumulation.
- Disrupting overall mitochondrial function is not a viable cancer therapy due to essential roles in normal cells.
- Targeting the specific communication pathways of mitochondrial ROS offers a therapeutic window.
Conclusions:
- Mitochondrial ROS signaling is a key driver of cancer phenotypes.
- Targeting mitochondria-to-cell redox communication presents a promising therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondria
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Peroxisomes

